Fundraising FoxAgilVax
Albuquerque, US · Founded 2011 · Delaware corporation · 1 known investors
Find your way into AgilVax
Sign up to find every way you can get introduced to AgilVax
- Your email: who you already know at AgilVax, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the AgilVax team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
FP
Federica PericleExecutive
JP
Joseph PattiNamed on SEC filing
EP
Ebetuel PallaresNamed on SEC filing
FC
Faith CharlesNamed on SEC filing
DE
Debora E RamirezNamed on SEC filing
Board
WT
BB
Brian BirkBoard director
BV
DB
SR
Stuart RoseBoard director
BE
Bill EnloeBoard director
Investors · 1
Funding
SEC filings, press & company announcements$4.2M disclosed across 2 of 3 rounds · 2014–2020
- Undisclosed amountSeries A-1Jan 2020Source ↗
▶$3MraisedAug 2019 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedAug 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph PattiExecutive Officer, Director
- Waneta TuttleDirector
- Ebetuel PallaresExecutive Officer, Director
- Brian BirkExecutive Officer, Director
- Faith CharlesDirector
- Brad ValeDirector
- Dee BresciaExecutive Officer
- Debora E RamirezExecutive Officer
- Offering amount
- $7.5M
- Amount sold
- $3M
- Minimum investment
- $100K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedJun 2014 · 4 investors · BiotechnologyRule 506(b)
▶$1.1MraisedJun 2014 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bill EnloeDirector
- Stuart RoseDirector
- Brian BirkDirector
- Waneta C TuttleDirector
- Federica PericleExecutive Officer, Director
- Ebetuel PallaresDirector
- Offering amount
- $5M
- Amount sold
- $1.1M
- Proceeds to insiders
- $600K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $298.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $286.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who are AgilVax's investors?
- AgilVax's investors include Tramway Venture Partners.
- How much funding has AgilVax raised?
- AgilVax has disclosed $4.2M raised across 2 of its 3 known rounds.
- Where is AgilVax headquartered?
- AgilVax is headquartered in Albuquerque, US.